A study by the Centers for Disease Control and Prevention proposes skin growth is not just a noteworthy general wellbeing issue in the United States, yet a huge financial weight too.
The study, distributed in the online release of the American Journal of Preventive Medicine, demonstrates the expense of treating the sickness in the United States has expanded five times quicker than the expense of treating every single other growth.
The CDC study found that skin disease treatment cost $3.6 billion amid the five-year period traversing 2002-2006. At that point, amid 2007-2011, the normal yearly cost took off to $8.1 billion - a 126 percent expansion.
The expense of treating every single other tumor climbed just 25 percent amid the same period, as per the study. It didn't focus why the expense of treating skin malignancy has risen to such an extent.
Skin growth is the most usually analyzed malignancy in the United States, and its rate is by all accounts on the ascent, in view of the study's discoveries. The CDC specialists found that the normal yearly number of grown-ups treated for skin tumor expanded from 3.4 million in 2002-2006 to 4.9 million in 2007-2011.
The most lethal type of skin tumor - melanoma - is frequently brought about by presentation to bright (UV) light.
General wellbeing authorities say the CDC's discoveries underscore the requirement for more skin malignancy aversion. They encourage you to:
Stay in the shade, particularly amid early afternoon hours;
Wear attire that covers your arms and legs;
Wear a cap with a wide overflow;
Wear shades that piece both bright An (UVA) and bright B (UVB) beams;
Utilization sunscreen with SPF 15 or higher and both UVA and UVB security; and
Abstain from tanning salons.
No comments:
Post a Comment